EP1901101A1 — Optical element unit and method of supporting an optical element
Assigned to Carl Zeiss SMT GmbH · Expires 2008-03-19 · 18y expired
What this patent protects
There is provided an optical element unit (102) comprising an optical element (107), a connector element (117), and an optical element holder (116). The optical element has a plane of main extension as well as an outer circumference and defines a radial direction. The connector e…
USPTO Abstract
There is provided an optical element unit (102) comprising an optical element (107), a connector element (117), and an optical element holder (116). The optical element has a plane of main extension as well as an outer circumference and defines a radial direction. The connector element (117) connects the optical element and the optical element holder, the connector element having a first connector part (117.1) connected to the optical element at the outer circumference and a second connector part (117.2) connected to the optical element holder. The first connector part and the second connector part are connected via at least one coupling part (117.3), the coupling part being compliant in the radial direction and substantially preventing rotation between the first connector part and the second connector part in a plane substantially parallel to the plane of main extension.
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.